CD47 and cancer: Although the loss of either CD47 or TSP1 in the tumor microenvironment greatly enhanced tumor ablation by ionizing radiation in several immune-competent cancer models [10,21], we also found that, in the absence of tumor irradiation, B16 melanomas grew moderately faster in cd47−/− mice [22].